Fear over transplant drug supply

Transplant patients could be at risk following a distribution change involving the supply of Tacrolimus to hundreds of dispensing practices, according to dispensing GPs.

Dr David Baker
Dr David Baker

Astellas Pharma, the manufacturer of Prograf, which contains Tacrolimus, will be shifting distribution to one wholesaler, Unichem, from the end of this month.

However the Dispensing Doctors Association (DDA) said that less than two weeks’ notice had been given, which does not give hundreds of dispensing practices time to get a Unichem account.

It is estimated that only 150 of the UK’s 1,400 dispensing practices currently have a Unichem account.

The DDA is meeting with Astellas to try to find a resolution, with options including asking for a U-turn on the single wholesaler move.

Dr David Baker, DDA chief executive, said the switch to a single supplier follows problems with not enough quantity of the treatment being made available.

‘It has told us that it has got the quantity right it’s just that some of it is going to other markets. By switching to a single wholesaler this gives it greater control but we are arguing that what there needs to be is more supply in the first place and to continue with multiple suppliers.’

Astellas has said in a statement that: ‘This change is in response to recent reports from UK pharmacists that they have had difficulties obtaining Prograf. We have acted with urgency to ensure the supply of these medicines to patients - taking the decision to distribute our transplant medicines directly to pharmacists and other dispensing points. We are confident this action will ensure the supply of these life saving medicines to UK patients.’

GPletters@haymarket.com

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GMC overhauls consent advice to improve patient involvement in decisions about care

GMC overhauls consent advice to improve patient involvement in decisions about care

The GMC has overhauled its guidance on patient consent - setting out seven key principles...

Government must show evidence behind PPE strategy, warns BMA

Government must show evidence behind PPE strategy, warns BMA

Chronic shortages of personal protective equipment (PPE) across the NHS during the...

Viewpoint: Bullying is a silent epidemic within the NHS

Viewpoint: Bullying is a silent epidemic within the NHS

There is a lack of training in general practice around understanding bullying, says...

HRT prescriptions lower in most deprived areas of England, study finds

HRT prescriptions lower in most deprived areas of England, study finds

Prescriptions for HRT are 29% lower in GP practices in England's most deprived areas...

Map: Which parts of England are most reliant on GPs aged over 55?

Map: Which parts of England are most reliant on GPs aged over 55?

More than two-fifths of the full-time equivalent (FTE) GP workforce is aged over...

Government outlines PPE supply plans as GPs remain in dark over reimbursement

Government outlines PPE supply plans as GPs remain in dark over reimbursement

The government has outlined plans to provide 'an uninterrupted supply' of PPE during...